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Background: The “25×25” strategy to tackle the global challenge of non-communicable diseases takes a traditional
approach, concentrating on a few diseases and their immediate risk factors.
Discussion: We propose elements of a comprehensive strategy to address NCDs that takes account of the evolving
social, economic, environmental and health care contexts, while developing mechanisms to respond effectively to local
patterns of disease. Principles that underpin the comprehensive strategy include: (a) a balance between measures that
address health at the individual and population level; (b) the need to identify evidence-based feasible and effective
approaches tailored to low and middle income countries rather than exporting questionable strategies developed in
high income countries; (c) developing primary health care as a universal framework to support prevention and treatment;
(d) ensuring the ability to respond in real time to the complex adaptive behaviours of the global food, tobacco, alcohol
and transport industries; (e) integrating evidence-based, cost-effective, and affordable approaches within the post-2015
sustainable development agenda; (f) determination of a set of priorities based on the NCD burden within each country,
taking account of what it can afford, including the level of available development assistance; and (g) change from a
universal “one-size fits all” approach of relatively simple prevention oriented approaches to more comprehensive
multi-sectoral and development-oriented approaches which address both health systems and the determinants of
NCD risk factors.
Summary: The 25×25 is approach is absolutely necessary but insufficient to tackle the the NCD disease burden of
mortality and morbidity. A more comprehensive approach is recommended.
Keywords: Non-communicable diseases, Prevention, Health systemsBackground
In 2011 world leaders met at the United Nations (UN) to
state their commitment to “to address the prevention and
control of non-communicable diseases worldwide” [1]. The
World Health Organization, as the UN’s specialised agency
for health, subsequently published its Global NCD Action
Plan 2013–2020 [2,3]. This proposes a series of voluntary
targets to tackle the emerging global epidemic of Non-
Communicable Diseases (NCDs) [4,5], with the goal of
achieving a 25% relative reduction in mortality from four
conditions (cardiovascular disease, cancer, diabetes and* Correspondence: martin.mckee@lshtm.ac.uk
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unless otherwise stated.chronic respiratory diseases) by 2025 [6]. The targets to
achieve this “25×25” strategy [7] include reducing mortality
from these four conditions and halting the rise in diabetes
and obesity, by reducing alcohol consumption, increasing
physical activity, reducing dietary salt and smoking, im-
proving blood pressure control, and enhancing treatment
of those at risk from or suffering from the major NCDs [8].
Yet, as we have argued elsewhere, these responses, which
might be considered the ‘standard’ model, are modest given
the scale of the challenge [9]. They will be insufficient to
respond to the global forces driving the epidemics of
NCDs, in particular the tobacco, alcohol and food indus-
tries, they are limited to four main NCDs which together
account for only 54% of NCD DALYS, and they pay insuffi-
cient attention to the non-traditional risk factors, such asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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this paper we argue for the need to go beyond this stand-
ard model and discuss seven key issues that a more com-
prehensive approach should consider.
Discussion
Balancing collective and individual responses
A comprehensive strategy should include an appropriate
balance of actions to prevent disease acting at the indi-
vidual and the collective and the local and the global
levels. All are important; there will always be a need for
individual-level interventions, especially for those at high
risk or with established disease, while there are some de-
terminants of disease, such as air pollution and inadequate
water supply that can only be tackled by collective action.
However, interventions at the population level often
achieve much greater benefits at lower cost. Similarly, po-
licies must be tailored to local contexts while tackling
shared regional or global threats.
The need for balance between the individual and the
collective can be illustrated with tobacco-attributable di-
sease [10]. At an individual level, existing smokers can
be helped with individual or group behavioural interven-
tions. Yet the main drivers of both smoking initiation
and cessation lie at the population level, related to price,
availability and marketing. Thus, increases in cigarette
prices are effective in reducing smoking, [11] including
in low- and middle-income countries [12]. Bans of point-
of-sale displays reduce perceived availability [13] and bans
on advertising in print media, radio and television serve to
de-normalise the act of smoking [14]. This is further en-
couraged by removal of the one place where advertising is
still permitted in many countries, the packs themselves,
with emerging data from Australia on how standardised
packaging reduces the attractiveness of smoking to young
people [15]. The population-level interventions are either
cost neutral or, in the case of tax rises, revenue raising,
while individual approaches always incur costs associated
with their delivery. The same principles apply to reducing
hazardous consumption of alcohol and certain food prod-
ucts. Thus, density of alcohol [16] outlets is an important
determinant of consumption while increases in alcohol
prices reduce hazardous consumption [17]. It is, however,
important to note that those selling these products will al-
ways argue against legislation and in favour of voluntary
agreements [18], precisely because the latter are known to
be less effective unless they incorporate clear targets and ro-
bust independent monitoring, which is rarely the case [19].
Collective measures often require action against “struc-
tural factors” or the “causes of the causes” [20] of disease.
These will require measures in areas as diverse as tax
and welfare, housing, transport, industry and agriculture,
sometimes brought together under the heading of “Health
in all Policies” [21]. This demands understanding of thecomplex and interrelated network of economic, environ-
mental, social, commercial, and cultural determinants in-
volved in health and the need for a range of integrated
actions involving all parts of government and not just
health ministries [22]. Although some actions to tackle
these determinants can be taken at the local or national
level, many will require concerted international responses.
Developing effective collective responses will be challen-
ging as, in many countries, and especially where govern-
ance is weak and transparency limited, health ministries
are the weakest within government and face opposition
from powerful vested interests with close links to other
stronger ministries and are often excluded from inter-
national discussions on key areas such as trade.
What works where?
The elements of a comprehensive strategy should be
appropriate to the settings in which they are applied. As
noted in the WHO Action Plan [2], it cannot be as-
sumed that technologies or policies developed in high-
income settings, where much of the evidence comes from,
can simply be transferred to low and middle-income
countries (LMIC), where the burden of disease is rising
rapidly. These approaches will often require unaffordable
levels of funding, skilled workers who do not exist, man-
agerial systems that are already struggling, and distribu-
tion systems unable to ensure regular supplies of essential
medicines [23]. Moreover, transfer of policies must also
take account of cultural norms. Thus, in many countries
in Asia, attempts to control hypertension must consider
traditional belief systems, such as those found in India,
China, and South East Asia, whereby “dis-ease” is equated
with pain and feeling ill and there is limited recognition of
the importance of treating an asymptomatic risk factor
[24]. It must also take account of affordability of both
treatment and the means of obtaining it (such as transport
costs), in countries where even a miniscule charge may be
unaffordable to families already trapped in a cycle of
debt [25].
Nor can it be assumed that policies developed in one
LMIC setting can be transferred to another at a similar
level of development, given the need to take account of
differences in implementation capacity, shared under-
standing of goals among those making and those imple-
menting policies and, sometimes corruption [26]. The
experience of scaling up HIV/AIDS services highlights
the problems that arise when applying costing data
derived in one setting to another where local data are
lacking [27].
There is an extensive literature on international lesson
learning and policy transfer [28] and approaches such as
“theory driven evaluation” [29] or “realist evaluation”
[30] go beyond the question whether something works
but rather to understand circumstances that make it
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creasingly in health policy research [31], many health-
related initiatives still ignore the context in which they
are to be applied.
For these reasons, it is essential to build a portfolio of
evidence on the cultural appropriateness, cost effective-
ness, and equity implications in different settings, based
on the creation of a culture of evaluation that runs
through the policy process, from generating locally rele-
vant evidence to translating it into formats that can be
used by policy makers, drawing especially on the emer-
ging body of evidence on knowledge translation in low
and middle income countries [32].
Strong primary health care
As noted in the WHO Action Plan [2], action against
NCDS should build on a foundation of strong primary
care. In 1978, in Alma Ata, 134 countries committed to
primary health care, defined as “the first level of contact
of individuals, the family and community with the na-
tional health system bringing health care as close as pos-
sible to where people live and work, and constituting the
first element of a continuing health care process” [33].
However, in over three decades since then, few health
systems have lived up to that commitment. Instead, often
encouraged by donors, many have invested in vertical
health programmes, targeting individual conditions, with
AIDS, tuberculosis, malaria, and more recently maternal
health attracting particular attention. Yet research on
health systems in countries at all levels of development
shows that integrated primary health care provides more
effective care and at lower cost than more fragmented sys-
tems [34] and countries that have adopted primary health
care achieve better health outcomes [35-37].
The common risk factors for NCDs increase the prob-
ability of multiple disorders. Poor diet increases the risk
of risk of diabetes, cardiovascular disease and some can-
cers, while smoking increases the risk of chronic ob-
structive pulmonary disease, cardiovascular disease, and
many cancers. Moreover, risk factors often cluster within
populations, disproportionately affecting those living in
deprived circumstances [38]. There is also an increasing
recognition of the growing rates of multi-morbidity in
ageing populations, including not just the four diseases
mentioned in the 25×25 strategy but also a wide range
of conditions such as mental illness and neurological
and musculo-skeletal diseases [39]. Crucially, many pa-
tients with chronic infectious disease, such as tubercu-
losis or HIV/AIDS, have co-existent NCDs [40,41].
There is little point in treating one condition but leaving
the patient with the consequences of several others.
An effective response must involve the provision of in-
tegrated health services, as close to the population as
possible, with no financial barriers to access. Yet this isoften far from reality. For example, people with type I
diabetes in many LMIC die because of lack of insulin
[42]. In a 2003 study from Mozambique it was estimated
that a child with type 1 diabetes could expect to live
3.8 years in Maputo, the capital, but only 7 months in
rural areas [43]. Hypertension is also poorly controlled
in many countries, with one recent study finding that
only 12.7 of those with hypertension are aware of it,
have received treatment, and achieved control, [44],
leading to much avoidable death and disability. These
challenges can only be addressed by a strong primary
care system that can identify and treat those in need in a
timely manner and, where necessary, refer them for
more specialised care.
Emerging threats
The 25×25 strategy addresses the traditional risk factors,
but not the underlying drivers of them. Just as mos-
quitoes are the vectors of the micro-organisms causing
some devastating communicable diseases, it is now re-
cognised that major corporations spread the traditional
risk factors for NCDS [45]. Trade liberalisation, itself a
major goal of these corporations that can exert a power-
ful influence on international regulations, is associated
with increases in a range of NCDs [46]. These corpora-
tions can move extremely quickly, as seen when once-
closed economies, such as countries emerging from the
USSR in the 1990s [47] and more recently, Myanmar,
open to the world. They exploit any regulatory gaps, for
example by placing brand imagery on consumer goods
(brand stretching) or using social media to circumvent
advertising bans. The major tobacco companies have
exploited the opportunities presented by electronic cig-
arettes to reposition themselves as partners with gov-
ernments in the fight against tobacco, while using the
ability to advertise these new products to promote im-
agery that glamorises smoking [48]. Unfortunately, le-
gislative processes are often very slow, and are slowed
even further by corporate pressure, as with the European
Union’s revision of the Tobacco Products Directive [49].
Consequently, there is a strong case for a global horizon
scanning function, identifying tactics used to promote un-
healthy products, coupled with support for rapid legisla-
tive responses, such as a repository for existing legislation
that can be adapted by other countries [50]. The alterna-
tive is that corporations will write the legislation, as hap-
pened when the tobacco industry assisted former Soviet
countries with tax codes that, unsurprisingly, were the
most favourable for their products. Effective action can-
not ignore the political roots of global health, including
what Kickbusch has termed the “commercial determi-
nants of health” [51], demanding effective global gov-
ernance based on commitments to global solidarity and
shared responsibility [52].
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The global response to NCDs should not stand in isola-
tion from other international processes. The post-2015
development agenda represents an important opportu-
nity to integrate efforts to reduce the burden of NCDs
and promote sustainable development [3]. The recent
identification of NCDs as a major threat to the global
economy [53,54] provides a lever for moving NCDs from
a peripheral to a central concern of global development.
It now seems likely that Universal Health Coverage
will feature prominently in the post-2015 development
agenda [55]. On 12 December 2012 it was endorsed
unequivocally by the UN General Assembly (including
the United States), which resolved that it confirmed
the “intrinsic role of health in achieving international
sustainable development goals” [56]. Universal Health
Coverage has been defined by the WHO as “access to
key promotive, preventive, curative and rehabilitative
health interventions for all at an affordable cost….”, sub-
ject to the proviso that the cost of care “…[should] not put
people at risk of financial catastrophe” [57]. Making it a
reality will require the implementation of evidence-based,
cost-effective, and affordable approaches that can re-
duce the burden of NCDs and promote sustainable de-
velopment [3,58].
The driving forces behind important risk factors for
NCDs, such as fine particulate air pollution , physical in-
activity and unhealthy diets, are linked to current patterns
of unsustainable development, including the combustion
of fossil fuels which results in climate change [58]. Indica-
tors for the post 2015 development agenda must therefore
link health and sustainability, addressing sectors such as
energy, transport, housing, food and agriculture [59] as
well as reflecting progress towards Universal Health
Coverage. However, current proposals fall far short of
what is needed [60].
Matching priorities to resources
An effective strategy must take account of the challenges
that each country faces and its access to resources. Each
country is at a different stage in the epidemiological
transition. Its burden of NCDs is influenced by the de-
mographic composition of its population, its exposure to
risk factors, its stage in the nutritional and epidemiological
transitions, its geography and its ability to provide effect-
ive health care [61]. For example, smoking-related disease
may be less in some countries because of cultural barriers
to smoking and limited penetration by tobacco corpora-
tions. While the debate about the role of thrifty genotypes
and phenotypes remains unresolved [62], it is clear that
some populations are much more susceptible to diabetes
than others. In many countries, diet continues to be influ-
enced heavily by traditional patterns of agriculture, even if
this is rapidly changing. Moreover, these differences areseen not only among countries but within them, with sub-
stantial regional differences in large countries such as
Brazil, India, or China, and between rural and urban areas
almost everywhere, with the NCD epidemic progressing
most rapidly in the latter.
Each country also has differing levels of available re-
sources, whether raised domestically or from develop-
ment assistance. Consequently, it will be essential that
strategies to tackle NCDs are matched to both the re-
sources available and the burden of disease, while not
forgetting the need to ensure equity. There is a critical
need to strengthen capacity in health ministries, which
often have a much lower status and priority than other
ministries, such as trade and defence. This will require a
comprehensive package of measures to recruit, develop
and retain skilled analysts and policy experts, supported
by access to information about both their own country
and the international literature on effective interven-
tions. This, in turn, will require new tools for surveil-
lance of NCDs and their risk factors, so far, these have
been largely missing from surveys such as the Demo-
graphic and Health Surveys that have concentrated on
maternal and child health and, more recently, HIV, as
well as a culture of evaluation of new policies and inter-
ventions. There is also a need for investment in capacity
to analyse the increased volume of data at sub-national
level so that national ‘norms’ do not lose sight of con-
centrations of disease, need and equity issues in particu-
lar settings.
At the same time as national capacity and capability is
built, there needs to be increased support for sub na-
tional health system development in districts and cities.
The front line of the organised response has been shat-
tered from decades of vertical programs. The NCD agenda
can add to this fragmentation, or alternatively take a com-
prehensive systems approach.
Progressive implementation of the 25×25 agenda
As the WHO Action Plan notes [2], countries responding
to the 25×25 agenda are starting from different points.
Some have almost no capacity to prevent and treat NCDs,
especially those emerging from conflict, while others have
some capacity, often concentrated in urban centres that
may function relatively well. Thus, a universal “one-size
fits all” approach will not be appropriate. Countries also
vary greatly in the extent to which they have moved from
a fragmented model that, at best, responds to immediate
demand to one that takes a broader view, employing an
integrated strategy that addresses the range of risk factors,
at both individual and collective level, and all steps along
the trajectory from disease detection to treatment, control,
and palliative care. Where resources, both in terms of
money, trained workers, and systems of governance are
limited, it will be necessary to start with interventions that
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Models of health care can be developed that involve mid-
level health workers, aided by simplified guidelines, and
with access to essential medicines. However, while the
starting points may differ, the end point should not. The
25×25 agenda sits alongside a number of other com-
mitments and policies. These include the International
Covenant on Economic, Social and Cultural Rights, which
established the commitment to progressive realisation of
the right to health by each state “to the maximum of its
available resources” [63] and the post-2015 agenda. The
most recent document (July 2014) from the Open
Working Group on the Sustainable Development Goals
proposes a target to “by 2030 reduce by one-third pre-
mature mortality from non-communicable diseases (NCDs)
through prevention and treatment [64]…”.
Thus, while countries will have to take account of avail-
able resources, there should be a clear vision of where
they want to be and what can be achieved as resources
increase, leading ultimately to more comprehensive,
multi-faceted, multi-sectoral and development-oriented
approaches integrating health and sustainability.Summary
In this paper we argue for the need to go beyond the
‘standard model’ of preventing NCDs, focussing only on
four risk factors (plus essential medicines for people at
high risk of CVD) and four diseases. We do not offer a
fully-developed strategy; rather, we argue that such a
strategy is needed and highlights some key features that
it should contain. These include: a) balancing collective
and individual responses in ways that protect health at
the individual level and view health as a common good;
b) identifying effective approaches tailored to LMICs ra-
ther than exporting questionable strategies developed in
HICs; c) strengthening health systems to support pre-
vention and treatment efforts, with an emphasis on pri-
mary health care; d) creating the ability to react in real
time to emerging threats, such as the complex adaptive
behaviours of the global food, tobacco, alcohol and
transport industries; e) adopting measures that promote
sustainable development, thereby advancing the post-
2015 agenda; f ) supporting prioritisation processes with-
in health systems that respond to the local disease
burden, what the country can afford, and the level of
development assistance, and that are informed by but
not overridden by global priorities; g) change from a
universal “one-size fits all” approach to a progression
from relatively simpler, public health oriented and af-
fordable approaches to more complex, multi-sectoral
and development oriented approaches. If these issues
are taken into account, the chances of success may
be considerably improved.Competing interests
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